Literature DB >> 22959032

Chemoprevention of melanoma.

Subbarao V Madhunapantula1, Gavin P Robertson.   

Abstract

Despite advances in drug discovery programs and molecular approaches for identifying drug targets, incidence and mortality rates due to melanoma continue to rise at an alarming rate. Existing preventive strategies generally involve mole screening followed by surgical removal of the benign nevi and abnormal moles. However, due to lack of effective programs for screening and disease recurrence after surgical resection, there is a need for better chemopreventive agents. Although sunscreens have been used extensively for protecting from UV-induced melanomas, results of correlative population-based studies are controversial, with certain studies suggest increased skin cancer risk in sunscreen users. Therefore, these studies require further authentication to conclusively confirm the chemoprotective efficacy of sunscreens. This chapter reviews the current understanding regarding melanoma chemoprevention and the various strategies used to accomplish this objective.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22959032      PMCID: PMC3628531          DOI: 10.1016/B978-0-12-397927-8.00012-9

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN: 1054-3589


  191 in total

1.  Resveratrol-mediated downregulation of Rictor attenuates autophagic process and suppresses UV-induced skin carcinogenesis.

Authors:  Jung H Back; Yucui Zhu; Alyssa Calabro; Craig Queenan; Audrey S Kim; Joshua Arbesman; Arianna L Kim
Journal:  Photochem Photobiol       Date:  2012-02-17       Impact factor: 3.421

Review 2.  Chemoprevention of melanoma: theoretical and practical considerations.

Authors:  Marie F Demierre; Vernon K Sondak
Journal:  Cancer Control       Date:  2005-10       Impact factor: 3.302

3.  Silymarin inhibits UV radiation-induced immunosuppression through augmentation of interleukin-12 in mice.

Authors:  Syed M Meeran; Suchitra Katiyar; Craig A Elmets; Santosh K Katiyar
Journal:  Mol Cancer Ther       Date:  2006-07       Impact factor: 6.261

4.  Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression.

Authors:  Hak-Su Kim; Myung-Jin Kim; Eun Ju Kim; Young Yang; Myeong-Sok Lee; Jong-Seok Lim
Journal:  Biochem Pharmacol       Date:  2011-11-19       Impact factor: 5.858

5.  Synthesis and characterization of a novel iNOS/Akt inhibitor Se,Se'-1,4-phenylenebis(1,2-ethanediyl)bisisoselenourea (PBISe)--against colon cancer.

Authors:  Dhimant Desai; SubbaRao V Madhunapantula; Krishnegowda Gowdahalli; Arati Sharma; Raghavendragowda Chandagaludoreswamy; Karam El-Bayoumy; Gavin P Robertson; Shantu Amin
Journal:  Bioorg Med Chem Lett       Date:  2009-09-22       Impact factor: 2.823

6.  Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers.

Authors:  P S Sunkara; N J Prakash; A L Rosenberger; A C Hagan; P J Lachmann; G D Mayer
Journal:  Cancer Res       Date:  1984-07       Impact factor: 12.701

7.  Effect of sunscreens on UV radiation-induced enhancement of melanoma growth in mice.

Authors:  P Wolf; C K Donawho; M L Kripke
Journal:  J Natl Cancer Inst       Date:  1994-01-19       Impact factor: 13.506

8.  Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells.

Authors:  Eric A Collisson; Celina Kleer; Mei Wu; Abhijit De; Sanjiv S Gambhir; Sofia D Merajver; Michael S Kolodney
Journal:  Mol Cancer Ther       Date:  2003-10       Impact factor: 6.261

9.  Non-steroidal anti-inflammatory drugs and melanoma risk: large Dutch population-based case-control study.

Authors:  Arjen Joosse; Elsje R Koomen; Mariël K Casparie; Ron M C Herings; Henk-Jan Guchelaar; Tamar Nijsten
Journal:  J Invest Dermatol       Date:  2009-07-09       Impact factor: 8.551

10.  Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.

Authors:  Craig A Elmets; Jaye L Viner; Alice P Pentland; Wendy Cantrell; Hui-Yi Lin; Howard Bailey; Sewon Kang; Kenneth G Linden; Michael Heffernan; Madeleine Duvic; Ellen Richmond; Boni E Elewski; Asad Umar; Walter Bell; Gary B Gordon
Journal:  J Natl Cancer Inst       Date:  2010-11-29       Impact factor: 13.506

View more
  7 in total

1.  Use of Nanoparticles in Delivery of Nucleic Acids for Melanoma Treatment.

Authors:  Mohammad A Obeid; Alaa A A Aljabali; Meriem Rezigue; Haneen Amawi; Hanin Alyamani; Shatha N Abdeljaber; Valerie A Ferro
Journal:  Methods Mol Biol       Date:  2021

2.  Mycobacterium indicus pranii (Mw) inhibits invasion by reducing matrix metalloproteinase (MMP-9) via AKT/ERK-1/2 and PKCα signaling: A potential candidate in melanoma cancer therapy.

Authors:  Kuntal Halder; Sayantan Banerjee; Sweta Ghosh; Anamika Bose; Shibali Das; Bidisha Paul Chowdhury; Subrata Majumdar
Journal:  Cancer Biol Ther       Date:  2015-09-21       Impact factor: 4.742

Review 3.  Nanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy: A Review.

Authors:  Roberta Balansin Rigon; Márcia Helena Oyafuso; Andressa Terumi Fujimura; Maíra Lima Gonçalez; Alice Haddad do Prado; Maria Palmira Daflon Gremião; Marlus Chorilli
Journal:  Biomed Res Int       Date:  2015-05-11       Impact factor: 3.411

4.  Liposome encapsulated luteolin showed enhanced antitumor efficacy to colorectal carcinoma.

Authors:  Guixia Wu; Jing Li; Jinqiao Yue; Shuying Zhang; Kurexi Yunusi
Journal:  Mol Med Rep       Date:  2017-11-29       Impact factor: 2.952

5.  KCNQ1OT1 promotes melanoma growth and metastasis.

Authors:  Bingyu Guo; Qian Zhang; Hongyi Wang; Peng Chang; Kai Tao
Journal:  Aging (Albany NY)       Date:  2018-04-17       Impact factor: 5.682

6.  MIR-520f Regulated Itch Expression and Promoted Cell Proliferation in Human Melanoma Cells.

Authors:  Ming-Xia Sun; Qun An; La-Mei Chen; Ling Guo
Journal:  Dose Response       Date:  2020-05-04       Impact factor: 2.658

7.  Rhabdoid melanoma in a harpy eagle (Harpia harpyja).

Authors:  César Augusto Pinzón-Osorio; Jersson Ávila-Coy; Arlen P Gomez; Diana Marcela Álvarez-Mira
Journal:  Vet Anim Sci       Date:  2021-06-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.